PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

Hui Yu; Cory Batenchuk; Andrzej Badzio; Theresa A. Boyle; Piotr Czapiewski; Daniel C. Chan; Xian Lu; Dexiang Gao; Kim Ellison; Ashley A. Kowalewski; Christopher J. Rivard; Rafal Dziadziuszko; Caicun Zhou; Maen Hussein; Donald Richards; Sharon Wilks; Marc Monte; William Edenfield; Jerome Goldschmidt; Ray Page; Brian Ulrich; David Waterhouse; Sandra Close; Jacek Jassem; Kimary Kulig; Fred R. Hirsch

doi:10.1016/J.JTHO.2016.09.002

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

Hui Yu
, Cory Batenchuk
, Andrzej Badzio
, Theresa A. Boyle
, Piotr Czapiewski
, Daniel C. Chan
, Xian Lu
, Dexiang Gao
, Kim Ellison
, Ashley A. Kowalewski
, Christopher J. Rivard
, Rafal Dziadziuszko
, Caicun Zhou
, Maen Hussein
, Donald Richards
, Sharon Wilks
, Marc Monte
, William Edenfield
, Jerome Goldschmidt
, Ray Page

Brian Ulrich, David Waterhouse, Sandra Close, Jacek Jassem, Kimary Kulig, Fred R. Hirsch

Anschutz Medical Campus
Bristol-Myers Squibb
Radiation Oncology Center NU-Med, Elblag, Poland.
Gdańsk Medical University
Tongji University
Florida Cancer Specialists and Research Institute, Ocala, Florida.
Texas Oncology
University of Texas at San Antonio
Clopton Clinic, Jonesboro, Arkansas.
Greenville Health System
Blue Ridge Cancer Care, Blacksburg, Virginia
The Center for Cancer and Blood Disorders, Fort Worth, Texas
Oncology Hematology Care, Cincinnati, Ohio.
Biostats Solutions, Frederick, Maryland.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Thoracic Oncology
Volume	12
Issue number	1
DOIs	https://doi.org/10.1016/J.JTHO.2016.09.002
State	Published - Jan 1 2017
Externally published	Yes

Disciplines

Molecular Biology
Biology
Oncology

Access to Document

10.1016/J.JTHO.2016.09.002License: Unspecified

Cite this

Yu, H., Batenchuk, C., Badzio, A., Boyle, T. A., Czapiewski, P., Chan, D. C., Lu, X., Gao, D., Ellison, K., Kowalewski, A. A., Rivard, C. J., Dziadziuszko, R., Zhou, C., Hussein, M., Richards, D., Wilks, S., Monte, M., Edenfield, W., Goldschmidt, J., ... Hirsch, F. R. (2017). PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer. Journal of Thoracic Oncology, 12(1). https://doi.org/10.1016/J.JTHO.2016.09.002

Yu, H, Batenchuk, C, Badzio, A, Boyle, TA, Czapiewski, P, Chan, DC, Lu, X, Gao, D, Ellison, K, Kowalewski, AA, Rivard, CJ, Dziadziuszko, R, Zhou, C, Hussein, M, Richards, D, Wilks, S, Monte, M, Edenfield, W, Goldschmidt, J, Page, R, Ulrich, B, Waterhouse, D, Close, S, Jassem, J, Kulig, K & Hirsch, FR 2017, 'PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer', Journal of Thoracic Oncology, vol. 12, no. 1. https://doi.org/10.1016/J.JTHO.2016.09.002

@article{4ba0b219d5464913aaad7fb361a905b3,

title = "PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer",

author = "Hui Yu and Cory Batenchuk and Andrzej Badzio and Boyle, \{Theresa A.\} and Piotr Czapiewski and Chan, \{Daniel C.\} and Xian Lu and Dexiang Gao and Kim Ellison and Kowalewski, \{Ashley A.\} and Rivard, \{Christopher J.\} and Rafal Dziadziuszko and Caicun Zhou and Maen Hussein and Donald Richards and Sharon Wilks and Marc Monte and William Edenfield and Jerome Goldschmidt and Ray Page and Brian Ulrich and David Waterhouse and Sandra Close and Jacek Jassem and Kimary Kulig and Hirsch, \{Fred R.\}",

note = "Therapeutic antibodies to immune checkpoints show promising results. Programmed death-ligand 1 (PD-L1), an immune checkpoint ligand, blocks the cancer immunity cycle by binding the PD-L1 receptor (programmed death 1). We investigated PD-L1 protein expression and messenger RNA (mRNA) levels in SCLC.",

year = "2017",

month = jan,

day = "1",

doi = "10.1016/J.JTHO.2016.09.002",

language = "American English",

volume = "12",

journal = "Journal of Thoracic Oncology",

number = "1",

}

TY - JOUR

T1 - PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

AU - Yu, Hui

AU - Batenchuk, Cory

AU - Badzio, Andrzej

AU - Boyle, Theresa A.

AU - Czapiewski, Piotr

AU - Chan, Daniel C.

AU - Lu, Xian

AU - Gao, Dexiang

AU - Ellison, Kim

AU - Kowalewski, Ashley A.

AU - Rivard, Christopher J.

AU - Dziadziuszko, Rafal

AU - Zhou, Caicun

AU - Hussein, Maen

AU - Richards, Donald

AU - Wilks, Sharon

AU - Monte, Marc

AU - Edenfield, William

AU - Goldschmidt, Jerome

AU - Page, Ray

AU - Ulrich, Brian

AU - Waterhouse, David

AU - Close, Sandra

AU - Jassem, Jacek

AU - Kulig, Kimary

AU - Hirsch, Fred R.

N1 - Therapeutic antibodies to immune checkpoints show promising results. Programmed death-ligand 1 (PD-L1), an immune checkpoint ligand, blocks the cancer immunity cycle by binding the PD-L1 receptor (programmed death 1). We investigated PD-L1 protein expression and messenger RNA (mRNA) levels in SCLC.

PY - 2017/1/1

Y1 - 2017/1/1

UR - https://europepmc.org/article/MED/27639678

U2 - 10.1016/J.JTHO.2016.09.002

DO - 10.1016/J.JTHO.2016.09.002

M3 - Article

VL - 12

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 1

ER -

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

Disciplines

Access to Document

Other files and links

Cite this